Market Access
Is the next generation of Chinese biotech ready to go global...
Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?
Sales & Marketing
The independent pharmacy opportunity pharma marketers are ov...
Pharma marketers often underestimate the value of independent pharmacies.
R&D
Sponsored
Turning recruitment potential into enrolment reality
In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Karen Townsend, senior director of medical affairs discusses SEELs
Oncology
Australia, CAR-T therapy, and solid tumours
Bev Menner, chief executive officer at Cell Therapies Pty Ltd, discusses CAR-T therapies for solid tumours and Australian and APAC R&D more generally.
Market Access
What the revised 340B rebate pilot programme means for pharm...
While the scope of the revised pilot is limited, it may be a harbinger for a broader policy shift.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
